Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3y1 (Ala-Ala) in the treatment of acute renal allograff rejection

Autor: Woodie, E.S., Xu, D., Zivin, R.A., Auger, J., Charette, J., O'Laughlin, R., Peace, D., Jolliffe, L.K., Haverty, T., Bluestone, J.A., Thistlethwaite, Jr, J.R.
Zdroj: Transplantation; Sep99, Vol. 68 Issue 5, p608, 8p
Databáze: Complementary Index